Lantern Pharma Inc.
Lantern Pharma develops oncology therapeutics guided by its RADR artificial intelligence platform for patient selection and biomarker-driven development.
8-KSep 30Latest SEC filing
Sep 30Latest story
Sign inSign inLantern Pharma develops oncology therapeutics guided by its RADR artificial intelligence platform for patient selection and biomarker-driven development.